glp-1 drugs in development Discovery of GLP-1–Based for the Treatment of Obesity Upcoming wave of hormone-based therapies
Description
Clinical studies and real-world evidence consistently showed that higher doses of drugs like Semaglutide and Tirzepatide led to greater reductions in body weight, which drove higher demand among both patients and prescribers
Over time, this can lead to a variety of health problems, including weight gain, high blood pressure, and an increased risk of type 2 diabetes
In these studies, insulin was discontinued, and patients were started on liraglutide at a low dose, which was subsequently titrated based on tolerance and need
They vary in their duration, formulation and other features
Pharmacology 86 (1), 4457
A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes
